Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H ( (HK:1858) ) has shared an announcement.
Beijing Chunlizhengda Medical Instruments Co., Ltd., a Hong Kong-listed Chinese medical instruments maker, operates through a group structure that includes multiple subsidiaries. Its board comprises executive, non-executive and independent non-executive directors, reflecting a standard listed-company governance framework.
The company has scheduled a board meeting for 30 March 2026 to approve its annual results for the year ended 31 December 2025 and to consider the payment of a final dividend. The outcome of this meeting will determine the company’s disclosed financial performance for 2025 and whether shareholders receive a final dividend, potentially influencing market expectations and investor sentiment.
The most recent analyst rating on (HK:1858) stock is a Buy with a HK$16.00 price target. To see the full list of analyst forecasts on Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H stock, see the HK:1858 Stock Forecast page.
More about Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H
Beijing Chunlizhengda Medical Instruments Co., Ltd. is a PRC-incorporated medical device manufacturer, listed in Hong Kong under stock code 1858. The company focuses on medical instruments, serving the healthcare sector through its operations in China and its group subsidiaries.
Average Trading Volume: 897,080
Technical Sentiment Signal: Sell
Current Market Cap: HK$7.76B
Learn more about 1858 stock on TipRanks’ Stock Analysis page.